T1	Participants 426 477	patients with relapsing-remitting multiple sclerosi
T2	Participants 551 653	76 centres in the Czech Republic, Germany, Hungary, India, Poland, Russia, Ukraine, Turkey, and the UK
T3	Participants 694 763	Patients aged 18-55 years with relapsing-remitting multiple sclerosis